Daha yüksek bir başarı için önce sağlık...
  1. Kaşıkçıoğlu E, Oflaz H, Akhan H, Kayserilioglu A, Umman B, Bugra Z. Aortic distensibility in endurance athletes. Acta Cardiologica 58(3):243-4 (2003).
  2. Kaşıkçıoğlu E, Kayserilioglu A, Yildiz S, Akhan H, Cuhadaroglu C. QT dispersion in soccer players during exercise testing. Int J Sports Med 25:177-81 (2004).
  3. Kaşıkcıoğlu E. Arrhtmogenic right ventricular cardiomyopathy and sudden cardiac death in young Koreans. Circ J 68: 401 (2004).
  4. Kaşıkçıoğlu E, Oflaz H, Akhan H, Kayserilioglu A, Mercanoglu F, Umman B, Bugra Z. Left ventricular remodeling and aortic distensibility in elite power athletes. Heart and Vessels 19:183-8 (2004).
  5. Kaşıkçıoğlu E, Cuhadaroglu C, Akhan H, Erkan F. ‘Pulmonary artery aneurysm in Behcet’s disease: a case report’. Heart and Vessels 19:157-9 (2004).
  6. Kaşıkçıoğlu E, Akhan H. Great vascular adaptation and cardiac remodelling in athletes. Heart (e-letter). (
  7. Kaşıkçıoğlu E, Aortic mechanical properties and left ventricular diastolic functions Heart (e-letter). (
  8. Kaşıkçıoğlu E, Akhan H. Echocardiographic limits of left ventricular remodeling in athletes. Journal of American College Cardiology 44:469-70 (2004).
  9. Kaşıkcıoğlu E. Left Ventricular Tei Index in Athletes. Eur J Echocardiogr 5:318 (2004).
  10. Oflaz H, TurkmenA, Kocaman O, Erdogan D, Meric M, Oncul A, Koylan N, Yilmaz E,Yilmaz C, Selcukbiricik F, Kaşıkcıoğlu E, Sever MS.Is there any relatıon between the duratıon of the cyclosporın a usage and right and left ventrıcular functıons in patıents wıth renal transplantatıon?: tissue doppler echocardıography study. Transplantation proceedings 36:1380-4 (2004).
  11. Mercanoglu F, Oflaz H, Turkmen A, Kocaman O, Bunyak B, Umman S, Yekeler E, Kaşıkcıoğlu E, Meric M, Demirel S, Kucuk M, Sever MS.Does the endothelial function hange in renal transplant patients with longer duration of exposure and with higher cumulative doses of Cyclosporin A? Transplantation proceedings 36:1361-6 (2004).
  12. Kaşıkcıoğlu E, Kayserilioglu A, Ciloglu F, Akhan H, Oflaz H, Yildiz S, Peker I. Angiotensin-converting enzyme gene polymorphism, left ventricular remodeling and exercise capacity in strength-trained athletes. Heart and Vessels 19:287-93 (2004).
  13. Kaşıkçıoğlu E, Oflaz H, Kaşıkçıoğlu HA, Kayserilioglu A, Umman S, Meric M. Endothelial flow-mediated dilatation and exercise capacity in highly trained endurance athletes. Tohoku J Exp Med. 2005 ;205(1):45-51
  14. Kaşıkçıoğlu E. Aortic elastic properties in athletes with Marfanoid habitus: the need for early and accurate diagnostic methods. Eur Heart J. 2005 ;26(1):100
  15. Kaşıkçıoğlu E, Oflaz H, Akhan H, Kayserilioğlu A, Umman S. Peak pulse pressure during exercise and left ventricular hypertrophy in athletes. Anadolu Kardiyol Derg. 2005;5(1):64-5
  16. Kaşıkçıoğlu E, Kayserilioglu A, Oflaz H, Akhan H. Aortic distensibility and left ventricular diastolic functions in endurance athletes. Int J Sports Med. 2005;26(3):165-70
  17. Kaşıkçıoğlu E. Anabolic-androgenic steroids: a bad tenor for cardiovascular orchestra (Myocardial infarction with intracoronary thrombus induced by anabolic steroids). Anadolu Kardiyol Derg. 2005;5(2):148-9
  18. Kaşıkçıoğlu E. QT dispersion and myocardial bridging. Int J Cardiol. 2005;102(3):523
  19. Kaşıkçıoğlu E, Oflaz H, Akhan H, Kayserilioglu A. Right ventricular myocardial performance index and exercise capacity in athletes. Heart Vessels. 2005;20(4):147-52.
  20. Kaşıkçıoğlu E. A difficult puzzle: right ventricular remodeling in athletes. Int J Cardiol. 2005 ;103(1):114
  21. Kaşıkçıoğlu E. Type of exercise and vascular remodelling. Biomed Pharmacother. 2005 Aug;59(7):421
  22. Kaşıkçıoğlu HA, Unal S, Tartan Z, Uyarel H, Okmen E, Kaşıkçıoğlu E, Cam N.Effects of levosimendan on left ventricular functional remodelling and exercise intolerance: a tissue Doppler study. J Int Med Res. 2005;33(4):397-405
  23. Kaşıkçıoğlu E. [The fragile point of cardiac rehabilitation: exercise compliance (The effects of phase II cardiac rehabilitation programme on patients who have undergone coronary bypass surgery)] Anadolu Kardiyol Derg. 2005 ;5(3):246-7
  24. Kaşıkçıoğlu HA, Karasulu L, Durgun E, Oflaz H, Kaşıkçıoğlu E, Cuhadaroglu C. Aortic elastic properties and left ventricular diastolic dysfunction in patients with obstructive sleep apnea. Heart Vessels. 2005 ;20(6):239-44.
  25. Kaşıkçıoğlu E. QT dispersion: is it a screening parameter for athletes who have high cardiovascular risk? Ann Noninvasive Electrocardiol. 2005;10(3):391
  26. Kaşıkçıoğlu E. The role of echocardiography screening in athletes for cardiovascular disease. Eur J Echocardiogr. 2006 ;7(2):182-3
  27. Kaşıkçıoğlu HA, Kaşıkçıoğlu E, Oflaz H, Unal S, Topcu B, Tartan Z, Arslan A, Cam N, Kayserilioglu A. Discrimination between physiologic and pathologic left ventricular dilatation. Int J Cardiol. 2006;109(2):288-90
  28. Kaşıkçıoğlu E.The Achilles point of cardiac cachexia: to exercise or not to exercise. Int J Cardiol. 2006;110(3):421-2
  29. Kaşıkçıoğlu E, Dinler M, Berker E. Reduced tolerance of exercise in fibromyalgia may be a consequence of impaired microcirculation initiated by deficient action of nitric oxide. Med Hypotheses. 2006;66(5):950-2
  30. Kaşıkçıoğlu E, Akhan H. Transthoracic echocardiography in pulmonary embolism: a diagnostic dilemma. Int J Cardiol. 2006 Mar 8;107(3):427.
  31. Kaşıkçıoğlu E, Arslan A, Topcu B, Sayli O, Akhan H, Oflaz H, Akin A, Kayserilioglu A, Meric M. Cardiac fatigue and oxygen kinetics after prolonged exercise. Int J Cardiol. 2006;108(2):286-8.
  32. Kaşıkçıoğlu E, Oflaz H, Akhan H, Kayserilioglu A, Umman B, Bugra Z, Erzengin F. Left atrial geometric and functional remodeling in athletes. Int J Sports Med. 2006 ;27(4):267-71.
  33. Oflaz H, Cuhadaroglu C, Pamukcu B, Meric M, Ece T, Kaşıkçıoğlu E, Koylan N. Endothelial function in patients with obstructive sleep apnea syndrome but without hypertension. Respiration. 2006;73(6):751-6.
  34. Kaşıkçıoğlu E. The other face of the medal: the risks of exercise training. J Am Coll Cardiol. 2006 Jul 4;48(1):220-1
  35. Kaşıkçıoğlu E. Which is the best parameter of submaximal cardiopulmonary exercise testing? Eur Heart J. 2006 ;27(20):2483.
  36. Kaşıkçıoğlu E. A Troia horse into cardiovascular system: anabolic steroid(s). Am J Cardiol. 2006 ;98(8):1122-3.
  37. Kaşıkçıoğlu E. Absolute parameters or mathematical models for the timing of cardiac transplantation. J Heart Lung Transplant. 2006;25(12):1483.
  38. Kaşıkçıoğlu E. How could sudden cardiac deaths on the athletic fields be prevented? Anadolu Kardiyol Derg. 2006;6(4):392-3.
  39. Kaşıkçıoğlu E. [Corridor walk tests and heart failure/ Quality of life and functional status in congestive heart failure] Anadolu Kardiyol Derg. 2007;7(1):95-6
  40. Kaşıkçıoğlu E, Oflaz H, Arslan A, Topcu B, Kaşıkçıoğlu HA, Umman B, Bugra Z, Kayserilioglu A. Aortic elastic properties in athletes using anabolic-androgenic steroids.Int J Cardiol. 2007 ;114(1):132-4.
  41. Dinler M, Kaşıkçıoğlu E, Akin A, Sayli O, Aksoy C, Oncel A, Berker E. Exercise capacity and oxygen recovery half times of skeletal muscle in patients with fibromyalgia. Rheumatol Int. 2007;27(3):311-3
  42. Kaşıkçıoğlu HA, Karasulu L, Tartan Z, Kaşıkçıoğlu E, Cuhadaroglu C, Cam N. Occult cardiac dysfunction in patients with obstructive sleep apnea syndrome revealed by tissue Doppler imaging. Int J Cardiol. 2007;118(2):203-5
  43. Kaşıkçıoğlu HA, Uyarel H, Tartan Z, Kaşıkçıoğlu E, Ozturk R, Cam N. Do calcium sensitizers affect right ventricular functions in patients with chronic heart failure? Int J Cardiol. 2007;118(2):246-8.
  44. Oflaz H, Kurt R, Cimen A, Elitok A, Onur I, Golcuk E, Demirturk M, Batmaz S, Kaşıkçıoğlu E. Coronary flow reserve is also impaired in patients with subclinical hypothyroidism. Int J Cardiol. 2007;120(3):414-6.
  45. Oflaz H, Sen F, Elitok A, Cimen AO, Onur I, Kaşıkçıoğlu E, Korkmaz S, Demirturk M, Kutluturk F, Pamukcu B, Ozbey N. Coronary flow reserve is impaired in patients with adult growth hormone (GH) deficiency. Clin Endocrinol (Oxf). 2007 ;66(4):524-9.
  46. Kaşıkçıoğlu E. From altus to parvus: cardiac fatigue in athletes. Eur Heart J. 2007;28(9):1171-2
  47. Kaşıkçıoğlu E. Gray zone problem in athletes. Eur Heart J. 2007 ;28(19):2415-6.
  48. Kaşıkçıoğlu E. The right ventricle: two roles for one actor. Eur Heart J. 2007;28(24):3094.
  49. Oflaz H, Kurt R, Sen F, Onur I, Cimen AO, Elitok A, Turkmen K, Pamukcu B, Kaşıkçıoğlu E, Bugra Z, Mercanoglu F, Ozbey N. Coronary flow reserve after L-thyroxine therapy in Hashimoto’s thyroiditis patients with subclinical and overt hypothyroidism. Endocrine. 2007 ;32(3):264-70
  50. Kaşıkçıoğlu E. [An algorithm for the differential diagnosis of physiologic and pathologic hypertrophy] Anadolu Kardiyol Derg. 2007;7(3):318-9.
  51. Farsidfar F, Kaşıkçıoğlu E, Oflaz H, Kaşıkçıoğlu D, Meric M, Umman S. Effects of different intensities of acute exercise on flow-mediated dilatation in patients with coronary heart disease. Int J Cardiol. 2008;124(3):372-4.
  52. Kaşıkçıoğlu E, Oflaz H, Oncul A, Kayserilioglu A, Umman S, Nisanci Y. The trivest in overreaching syndrome: cardiac fatigue, muscular weakness, and vascular dysfunction. Int J Cardiol. 2008;127(3):417-9.
  53. Kaşıkçıoğlu E, Elitok A, Onur I, Cimen A, Ucar A, Oflaz H. Acute effects of smoking on coronary flow velocity reserve and ventricular diastolic functions. Int J Cardiol. 2008;129(1):e18-20.
  54. Kaşıkçıoğlu E, Oflaz H, Umman B, Bugra Z. Androgenic anabolic steroids also impair right ventricular function. Int J Cardiol. 2009;134(1):123-5.
  55. Turkmen K, Oflaz H, Uslu B, Cimen AO, Elitok A, Kaşıkçıoğlu E, Alisir S, Tufan F, Namli S, Uysal M, Ecder T. Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries. Clin J Am Soc Nephrol. 2008;3(4):986-91
  56. Oflaz H, Sen F, Bayrakli SK, Elitok A, Cimen AO, Golcuk E, Kaşıkçıoğlu E, Tukenmez M, Yazici H, Turkmen A. Reduced coronary flow reserve and early diastolic filling abnormalities in patients with nephrotic syndrome. Ren Fail. 2008;30(9):914-20.
  57. Dinler M, Diracoglu D, Kaşıkçıoğlu E, Sayli O, Akin A, Aksoy C, Oncel A, Berker E. Effect of aerobic exercise training on oxygen uptake and kinetics in patients with fibromyalgia. Rheumatol Int. 2009;30(2):281-4.
  58. Kaşıkçıoğlu E, Toker A, Tanju S, Arzuman P, Kayserilioglu A, Dilege S, Kalayci G. Oxygen uptake kinetics during cardiopulmonary exercise testing and postoperative complications in patients with lung cancer. Lung Cancer. 2009;66(1):85-8. (PROF.DR. GÖKSEL KALAYCI’nın anısına atfedilmiştir.)
  59. Kaşıkçıoğlu E. Importance of automatic external defibrillator:save a life in athletic fields. J Sports Science and Medicine 2009;49:489-490.
  60. Alisir S, Turkmen K, Alpay N, Elitok A, Oflaz H, Uslu B, Cimen A, Kaşıkçıoğlu E, Tufan F, Ecder T. Improvement of coronary flow velocity reserve with telmisartan in patients with autosomal-dominant polycystic kidney disease. South Med J. 2010;103(5):409-13.